These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 661200)

  • 21. Thrombophlebitis of the lower extremities and ABO blood type.
    Jick H; Porter J
    Arch Intern Med; 1978 Oct; 138(10):1566-7. PubMed ID: 708180
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Masquerading venous thrombosis.
    Talbot S
    Br J Clin Pract; 1975 May; 29(5):109-13. PubMed ID: 1191493
    [No Abstract]   [Full Text] [Related]  

  • 23. [Significance of hyperuricemia in chronic arterial occlusive disease and in post-thrombotic syndrome].
    Marx H
    Verh Dtsch Ges Kreislaufforsch; 1974; 40():233-5. PubMed ID: 4450657
    [No Abstract]   [Full Text] [Related]  

  • 24. Fibrinolytic and inflammatory markers for arterial occlusion: the evolving epidemiology of thrombosis and hemostasis.
    Ridker PM
    Thromb Haemost; 1997 Jul; 78(1):53-9. PubMed ID: 9198127
    [No Abstract]   [Full Text] [Related]  

  • 25. The muscle as a possible source of plasminogen activator to the blood and their therapeutic implication in the prevention of deep vein thrombosis.
    Menon IS
    Acta Univ Carol Med Monogr; 1972; 52():181-4. PubMed ID: 4669820
    [No Abstract]   [Full Text] [Related]  

  • 26. [Predisposing factors for thrombosis].
    Boneu B
    Nouv Rev Fr Hematol (1978); 1993 Jun; 35(3):187-90. PubMed ID: 8337121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Attention to arterial thrombotic diseases].
    Li JZ
    Zhonghua Nei Ke Za Zhi; 2006 Jan; 45(1):2-3. PubMed ID: 16624073
    [No Abstract]   [Full Text] [Related]  

  • 28. Arterial thrombosis: putative role of lipoprotein(a).
    El LT; Brown BM
    Crit Care Nurs Clin North Am; 1993 Sep; 5(3):435-43. PubMed ID: 8217039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [ABO/H blood groups and factor V Leiden].
    Matýsková M; Zavrelová J; Pejchalová A; Meluzinová H; Janků L
    Cas Lek Cesk; 2002 Mar; 141(5):146-51. PubMed ID: 11998221
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blood viscosity, mass transport, and thrombogenesis.
    Turitto VT
    Prog Hemost Thromb; 1982; 6():139-77. PubMed ID: 6762611
    [No Abstract]   [Full Text] [Related]  

  • 31. The TFPI 536C-->T mutation is not associated with increased risk for venous or arterial thrombosis.
    González-Conejero R; Lozano ML; Corral J; Martínez C; Vicente V
    Thromb Haemost; 2000 May; 83(5):787-8. PubMed ID: 10823280
    [No Abstract]   [Full Text] [Related]  

  • 32. Reassessment of ABO blood group, sex, and age on laboratory parameters used to diagnose von Willebrand disorder: potential influence on the diagnosis vs the potential association with risk of thrombosis.
    Favaloro EJ; Soltani S; McDonald J; Grezchnik E; Easton L; Favaloro JW
    Am J Clin Pathol; 2005 Dec; 124(6):910-7. PubMed ID: 16416741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Arterial thrombosis and the role of thrombophilia.
    Boekholdt SM; Kramer MH
    Semin Thromb Hemost; 2007 Sep; 33(6):588-96. PubMed ID: 17768691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between ABO and Secretor genotype with plasma levels of factor VIII and von Willebrand factor in thrombosis patients and control individuals.
    Schleef M; Strobel E; Dick A; Frank J; Schramm W; Spannagl M
    Br J Haematol; 2005 Jan; 128(1):100-7. PubMed ID: 15606555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and impact of donor-type red blood cell transfusion before allogeneic peripheral blood progenitor cell transplantation with major ABO mismatch.
    Scholl S; Klink A; Mügge LO; Schilling K; Höffken K; Sayer HG
    Transfusion; 2005 Oct; 45(10):1676-83. PubMed ID: 16181220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thrombophilic genotypes, natural anticoagulants, and plasma homocysteine in myeloproliferative disorders: relationship with splanchnic vein thrombosis and arterial disease.
    Amitrano L; Guardascione MA; Ames PR; Margaglione M; Antinolfi I; Iannaccone L; Annunziata M; Ferrara F; Brancaccio V; Balzano A
    Am J Hematol; 2003 Feb; 72(2):75-81. PubMed ID: 12555209
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preface: platelets in inflammation and atherothrombosis.
    Michiels JJ; Gawaz M
    Semin Thromb Hemost; 2007 Mar; 33(2):119-22. PubMed ID: 17340458
    [No Abstract]   [Full Text] [Related]  

  • 38. [On the occlusions of retinal vessels].
    Meythaler H
    Klin Monbl Augenheilkd; 1966; 149(1):32-41. PubMed ID: 5966438
    [No Abstract]   [Full Text] [Related]  

  • 39. [Venous thromboembolic disease and Klinefelter's syndrome].
    Wautrecht JC; Vincent G; Dereume JP
    J Mal Vasc; 1986; 11(2):125-7. PubMed ID: 2941508
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Blood groups as a risk factor in venous thrombosis].
    Hernández Cañete CM; Alvarez Dieguez R; González Sánchez M de la C; Díaz Hernández C; Sánchez Montiel ME
    Angiologia; 1993; 45(5):180-3. PubMed ID: 8285366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.